StemCutis, LLC Report issue

For profit Phase 2
Founded: San Diego CA United States (2014)
Status: No NME R&D (2014)

Organization Overview

First Clinical Trial
2015
NCT01771679
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2015

Timeline

NOW
  • Now

Alternative names

StemCutis, LLC - A Stemedica Company

Active Ingredients

Drugs in Phase 2 Trials (1)

allogeneic adipose derived mesenchymal stem cell (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Skin Diseases (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 1
  • # of Trial APIs: 1